Michael G Kaplitt Selected Research

Michael G Kaplitt Research Topics

Disease

13	Parkinson Disease (Parkinson's Disease) 11/2021 - 10/2006
4	Neoplasms (Cancer) 10/2015 - 03/2004
3	Inflammation (Inflammations) 12/2022 - 10/2017
3	Parkinsonian Disorders (Parkinsonism) 11/2021 - 04/2011
3	Dyskinesias (Dyskinesia) 01/2017 - 02/2016
2	Brain Neoplasms (Brain Tumor) 01/2021 - 09/2006
2	Hemorrhage 06/2019 - 10/2017
2	Substance-Related Disorders (Drug Abuse) 02/2016 - 01/2015
2	Major Depressive Disorder (Major Depressive Disorders) 01/2016 - 07/2012
2	Neuronal Ceroid-Lipofuscinoses (Neuronal Ceroid Lipofuscinosis) 10/2012 - 05/2008
2	Ototoxicity 04/2007 - 06/2006
1	Infections 06/2019
1	Encephalitis (Encephalitis, Rasmussen) 01/2018
1	Alzheimer Disease (Alzheimer's Disease) 01/2018
1	Pathologic Processes 10/2017
1	Calcinosis 10/2017
1	Tremor (Tremors) 02/2016
1	Carcinogenesis 01/2015
1	Glioblastoma (Glioblastoma Multiforme) 01/2015
1	Movement Disorders (Movement Disorder) 01/2015
1	Pain (Aches) 01/2015
1	Disease Progression 08/2014
1	Brain Diseases (Brain Disorder) 08/2014
1	Huntington Disease (Huntington's Disease) 07/2014
1	Chorea (Rheumatic Chorea) 07/2014
1	Plague (Bubonic Plague) 07/2014
1	Nervous System Diseases (Neurological Disorders) 09/2013
1	Mental Disorders (Mental Disorder) 09/2013
1	Persistent Vegetative State (Vegetative State) 01/2013
1	Nausea 04/2011
1	Headache (Headaches) 04/2011
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2009
1	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2007
1	Functional Hearing Loss 04/2007
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 02/2007
1	Obesity 02/2007
1	Hyperphagia (Overeating) 02/2007
1	Glioma (Gliomas) 09/2006
1	Hearing Loss (Hearing Impairment) 06/2006

Drug/Important Bio-Agent (IBA)

7	Levodopa (L Dopa)FDA LinkGeneric 11/2021 - 10/2006
4	Dopamine (Intropin)FDA LinkGeneric 11/2021 - 10/2015
3	salicylhydroxamic acid (SHAM)IBA 01/2017 - 04/2011
3	Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA 01/2017 - 06/2007
2	Pharmaceutical PreparationsIBA 12/2020 - 02/2016
2	Proteins (Proteins, Gene)FDA Link 01/2018 - 01/2016
2	Therapeutic UsesIBA 02/2016 - 06/2006
2	Cisplatin (Platino)FDA LinkGeneric 04/2007 - 06/2006
2	CaspasesIBA 04/2007 - 06/2006
1	CXCR4 Receptors (CXCR4 Receptor)IBA 12/2022
1	plerixafor FDA Link 12/2022
1	Apolipoprotein E2IBA 01/2018
1	Trace Elements (Biometals)IBA 10/2017
1	Contrast MediaIBA 10/2017
1	IronIBA 10/2017
1	Cholinergic Agents (Cholinergics)IBA 02/2016
1	Sirolimus (Rapamycin)FDA Link 02/2016
1	AcetyltransferasesIBA 02/2016
1	Tacrine (Cognex)FDA Link 02/2016
1	Phosphoprotein Phosphatases (Phosphatases, Protein)IBA 10/2015
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 10/2015
1	LipidsIBA 10/2015
1	TensinsIBA 10/2015
1	Glycogen Synthase Kinase 3 betaIBA 01/2015
1	Serine (L-Serine)FDA Link 01/2015
1	Okadaic AcidIBA 01/2015
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 07/2014
1	trkB ReceptorIBA 07/2014
1	Tripeptidyl-Peptidase 1IBA 10/2012
1	Biological ProductsIBA 07/2012
1	gamma-Aminobutyric Acid (GABA)IBA 04/2011
1	Peptide Hydrolases (Proteases)FDA Link 09/2009
1	Phosphotransferases (Kinase)IBA 01/2009
1	alpha-SynucleinIBA 01/2009
1	Complementary DNA (cDNA)IBA 05/2008
1	Biomarkers (Surrogate Marker)IBA 12/2007
1	X-Linked Inhibitor of Apoptosis ProteinIBA 04/2007
1	Indicators and Reagents (Reagents)IBA 04/2007
1	PhalloidineIBA 04/2007
1	Estrogen Receptor alphaIBA 02/2007
1	Glucose (Dextrose)FDA LinkGeneric 02/2007
1	AdrenomedullinIBA 09/2006
1	Peptides (Polypeptides)IBA 09/2006
1	EnzymesIBA 06/2006
1	Nerve Growth Factor (NGF)IBA 03/2004

Therapy/Procedure

5	Therapeutics 01/2021 - 10/2006
4	Deep Brain Stimulation 01/2015 - 10/2006
1	Immunotherapy 01/2021
1	Drug Therapy (Chemotherapy) 01/2021
1	Pallidotomy 12/2020
1	Laser Therapy (Surgery, Laser) 06/2019
1	Biological Therapy 01/2015
1	Cell Transplantation 01/2015
1	Spinal Cord Stimulation 01/2013
1	Electrodes (Electrode) 06/2009
1	Investigational Therapies (Experimental Therapy) 12/2007